BAYRY News and Press, Bayer AG ADR From 10/26/22

Bayer ( OTCPK:BAYZF ) ( OTCPK:BAYRY ) on Wednesday said Canada's drug regulator had approved its Kerendia medicine as an adjunct to standard of care for the treatment of chronic kidney disease (CKD) and type 2 diabetes (T2D). An adjunct is an additional treatment that is u...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Ginkgo Bioworks (NYSE: DNA ) stock has been making headlines left and right this month. The company has announced several new collaborations and acquisitions . Since Oct. 4, the cell programming company has acquired ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips With all the vagaries in the market these days, investors may be better served considering undervalued biotech stocks to buy. At the most basic level, biotechnology firms aim to address critical vulnerabilities in the human...

Summary European stocks - including Bayer - we punished in the last few months, and the potential energy crisis could be a reason. But Bayer is reporting solid quarterly results and could increase its fiscal 2022 guidance. The company is also recession-resilient and might prof...

Bayer ( OTCPK:BAYZF ) ( OTCPK:BAYRY ) on Monday said it expanded the late-stage development program for elinzanetant by starting a phase 3 study in patients with breast cancer and women with high risk for breast cancer with vasomotor symptoms (VMS) caused by endocrine...

Summary Inflation and (expected) actions by the Federal Reserve continue to dominate market movements. Markets remain very volatile following record inflation readings paired with an aggressive Fed and negative consumer sentiment. US inflation is softening in July but continues to...

Bayer ( OTCPK:BAYRY ) ( OTCPK:BAYZF ) said Friday it plans to challenge a U.S. jury verdict awarding $275M to a group of people claiming they suffered from exposure to PCB, a chemical the company's Monsanto business produced until 1977. Thursday's verdict at the King Cou...

Bayer ( OTCPK:BAYRY ) ( OTCPK:BAYZF ) said on Oct. 5 that it completed selling its Environmental Science Professional business to Private equity firm Cinven for $2.6B. The Cary, N.C.-based divested business — which provides solutions to control pests, ...

Summary Harris Associates’ 13F portfolio value decreased from $75.90B to $62.85B this quarter. They increased Amazon.com, Meta Platforms, and Salesforce while reducing Keurig Dr. Pepper, Humana, Regeneron Pharma, CVS Health, Constellation Brands, and General Dynamics. T...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips In arguably most cases, investors should concentrate the bulk of their portfolio on high-quality names, irrespective of catchy marketing schemes like under-$20 sleeper stocks to buy. Usually, comfort (and confidence) exists...